Talkspace ROE 2020-2025 | TALK
Current and historical return on equity (ROE) values for Talkspace (TALK) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Talkspace ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $0.00B | $0.11B | 2.60% |
| 2024-12-31 | $0.00B | $0.12B | 1.71% |
| 2024-09-30 | $0.00B | $0.12B | 0.00% |
| 2024-06-30 | $-0.01B | $0.11B | -5.10% |
| 2024-03-31 | $-0.01B | $0.12B | -9.22% |
| 2023-12-31 | $-0.02B | $0.12B | -15.87% |
| 2023-09-30 | $-0.04B | $0.12B | -29.51% |
| 2023-06-30 | $-0.05B | $0.12B | -38.99% |
| 2023-03-31 | $-0.07B | $0.12B | -49.45% |
| 2022-12-31 | $-0.08B | $0.13B | -52.32% |
| 2022-09-30 | $-0.08B | $0.14B | -49.10% |
| 2022-06-30 | $-0.06B | $0.16B | -33.88% |
| 2022-03-31 | $-0.07B | $0.18B | -35.52% |
| 2021-12-31 | $-0.06B | $0.19B | -40.92% |
| 2021-09-30 | $-0.06B | $0.21B | -76.19% |
| 2021-06-30 | $-0.07B | $0.20B | -230.09% |
| 2021-03-31 | $-0.04B | $0.01B | 171.43% |
| 2020-12-31 | $-0.02B | $-0.10B | 103.37% |
| 2020-06-30 | $0.00B | $0.01B | -80.00% |
| 2020-03-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.419B | $0.188B |
| Talkspace Inc. is a virtual behavioral healthcare company. It delivered services through an easy-to-use and fully encrypted web and mobile platform, consistent with HIPAA and other state regulatory requirements. The company offers treatment options for almost every need. Talkspace Inc., formerly known as Hudson Executive Investment Corp., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.009B | 57.26 |
| Doximity (DOCS) | United States | $11.611B | 51.52 |
| Tempus AI (TEM) | United States | $11.485B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $10.735B | 88.82 |
| IRhythm Technologies (IRTC) | United States | $5.216B | 0.00 |
| Hinge Health (HNGE) | United States | $4.368B | 0.00 |
| Privia Health (PRVA) | United States | $2.542B | 188.27 |
| Inspire Medical Systems (INSP) | United States | $2.482B | 36.49 |
| Phreesia (PHR) | United States | $1.657B | 0.00 |
| Enovis (ENOV) | United States | $1.643B | 8.69 |
| 10x Genomics (TXG) | United States | $1.577B | 0.00 |
| Omnicell (OMCL) | United States | $1.449B | 27.91 |
| Schrodinger (SDGR) | United States | $1.383B | 0.00 |
| Azenta (AZTA) | United States | $1.339B | 58.42 |
| Clover Health Investments (CLOV) | United States | $1.272B | 0.00 |
| Claritev (CTEV) | United States | $1.080B | 0.00 |
| Evolent Health (EVH) | United States | $1.033B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.643B | 0.00 |
| Veradigm (MDRX) | United States | $0.503B | 0.00 |
| Standard BioTools (LAB) | United States | $0.498B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.496B | 0.00 |
| Carlsmed (CARL) | $0.351B | 0.00 | |
| Butterfly Network (BFLY) | United States | $0.350B | 0.00 |
| TruBridge (TBRG) | United States | $0.294B | 51.53 |
| Nyxoah SA (NYXH) | Belgium | $0.228B | 0.00 |
| Outset Medical (OM) | United States | $0.225B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.212B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.211B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.192B | 0.00 |
| CapsoVision (CV) | United States | $0.188B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.136B | 0.00 |
| American Well (AMWL) | United States | $0.110B | 0.00 |
| CareCloud (CCLD) | United States | $0.107B | 4.87 |
| EUDA Health Holdings (EUDA) | Singapore | $0.096B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.093B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.072B | 0.00 |
| Pulmonx (LUNG) | United States | $0.065B | 0.00 |
| 111 (YI) | China | $0.058B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.041B | 0.00 |
| Zhongchao (ZCMD) | China | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.018B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |